about
Antipsychotic drug treatment for elderly people with late-onset schizophreniaGABAergic interneuron origin of schizophrenia pathophysiology.Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsForeign Accent Syndrome As a Psychogenic Disorder: A Review.Multiple D2 heteroreceptor complexes: new targets for treatment of schizophreniaThe cytokine model of schizophrenia: emerging therapeutic strategiesThe impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophreniaVesicular neurotransmitter transporters. Potential sites for the regulation of synaptic functionOpinion: NK3 receptor antagonists: the next generation of antipsychotics?Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?Altered serine/threonine kinase activity in schizophreniaMolecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.Nonhuman primate model of schizophrenia using a noninvasive EEG method.Reward processing in autism: a thematic series.Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration.The development of psychotic disorders in adolescence: a potential role for hormonesAn astroglia-linked dopamine D2-receptor action in prefrontal cortex.Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.Effect of the acute and chronic administration of the selective 5-HT6 receptor antagonist SB-271046 on the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia.Cholecystokinin A receptor (CCKAR) gene variation is associated with language lateralizationProvocative tests with psychostimulant drugs in schizophrenia.Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.Resting-state functional connectivity of the nucleus accumbens in auditory and visual hallucinations in schizophrenia.Mood responses of remitted schizophrenics to methylphenidate infusion.Polydipsia, hyponatremia and rhabdomyolysis in schizophrenia: A case report.Blockade of phencyclidine-induced effects by a nitric oxide donorNo association of DRD2, DRD3, and tyrosine hydroxylase gene polymorphisms with personality traits in the Japanese population.Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.Levels of explanation in psychiatric and substance use disorders: implications for the development of an etiologically based nosologyEffect of chronic neuroleptic treatment on central and peripheral muscarinic receptorsStriatal dopamine receptor plasticity in neurotensin deficient mice.Elevated dopa decarboxylase activity in living brain of patients with psychosis.Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol AdministrationExamining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study.Cholecystokinin antagonists--a toxicologic perspective.Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain.
P2860
Q24203649-AF34041B-0AB3-4CBD-A5EA-75F336169CFAQ24597790-137AFA40-698A-455C-9466-AEBD8DF0DB13Q26741541-98A9BAB2-239A-49C4-8C53-E68A6AEAA08CQ26747541-88743885-479A-4A2E-A21A-02558A460183Q26747736-AA6FA33C-1BC5-4890-8D9F-9E199E355CA0Q26865996-2B70F306-2A15-4C09-BF89-8812863E043BQ28081110-EA83BC48-EBE3-477B-BC44-535B2D736EDFQ28256325-4678462C-5CA0-4BB1-AB80-E6CB572F31EEQ28286127-5370719C-DD69-42E7-9D66-394C33DD11FCQ28366409-0CA56D0E-5A2D-44C4-B320-D046076938B4Q30409979-7E182438-8F79-4B5A-996D-EDE1BFB01212Q30428213-1B21994F-0B8D-4E99-9BA6-5E1273073957Q30448209-9D3E1180-B855-455F-8AFB-9E850BF093E2Q30462673-17CC1D76-6F5E-41F1-9B74-36E7EFAC60B7Q30492329-B72FA413-27A7-4844-B623-17235AC12F29Q31949056-E55C8773-05E0-453E-9E4A-9FC46C582A6BQ33806650-C74014AE-18EA-43D6-B228-FFEA3A75454BQ34115031-9C5606F9-EADF-4C31-BEFB-F002AA59DBDAQ34151743-35129B6E-07E8-4E43-BDA3-901952F4AC93Q34294017-F0131102-7853-4045-B244-1BE310AA2E89Q34423308-EB9403C6-8369-4DC7-8A66-B2BFED521833Q34449655-37D53AA7-DF73-4603-BB14-9D9C364518AEQ34558539-31771828-C752-41FC-AB5D-02A99A1A15E2Q34559517-BAFFE1FF-5215-4BC0-80A3-6A62183D9030Q34660675-76343CB5-730B-4FD0-AFC5-80C0F9235E41Q34661211-B452F857-2300-4E22-902C-F337C8ADE747Q34701047-0E6BC909-E774-4FEB-85EC-57E41982CD44Q34706802-D8B475CF-3065-4AC9-B2CA-7727FDCFCE1EQ34761293-608E3C46-2043-470E-983B-335055688183Q35042417-646BABAC-E2AD-4CAA-A751-B7DF44FC776DQ35082762-B0724FA7-02D5-4AAD-A80E-0916BE95BE77Q35273514-14A284C3-802B-4A45-9111-BFB6D294BDD1Q35549278-25728907-28E7-4474-917F-C98C02C01004Q35759732-9107091A-B591-4647-B5E3-11FBCBADBA11Q35834247-E11701BC-B7DA-4C03-AFE5-9EE76B7FD9F0Q35927690-D722D300-372C-43D8-9B8D-4EC85FD5DB10Q35987580-9219A184-0AEB-4748-9AAE-F1E5102F4894Q36011922-611AE9A3-C403-4B09-B336-E19EEECD7221Q36071597-3BDE7DA1-9632-41CE-AC26-BF921BECB8BFQ36186550-209E9F56-0D2B-4A7B-B4A7-80E05708F210
P2860
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
The dopamine hypothesis of schizophrenia: a review.
@en
type
label
The dopamine hypothesis of schizophrenia: a review.
@en
prefLabel
The dopamine hypothesis of schizophrenia: a review.
@en
P356
P1476
The dopamine hypothesis of schizophrenia: a review.
@en
P2093
P356
10.1093/SCHBUL/2.1.19
P407
P577
1976-01-01T00:00:00Z